Literature DB >> 12576974

Treatment of space-occupying cerebral infarction.

Jeannette Hofmeijer1, H Bart van der Worp, L Jaap Kappelle.   

Abstract

OBJECTIVE: Patients with a hemispheric infarct accompanied by massive edema have a poor prognosis; the case fatality rate may be as high as 80%, and most survivors are left severely disabled. Various treatment strategies have been proposed to limit brain tissue shifts and to reduce intracranial pressure, but their use is controversial. We performed a systematic search of the literature to review the evidence of efficacy of these therapeutic modalities. DATA SOURCES: Literature searches were carried out on MEDLINE and PubMed. STUDY SELECTION: Studies were included if they were published in English between 1966 and February 2002 and addressed the effect of osmotherapy, hyperventilation, barbiturates, steroids, hypothermia, or decompressive surgery in supratentorial infarction with edema in animals or humans. DATA SYNTHESIS: Animal studies of medical treatment strategies in focal cerebral ischemia produced conflicting results. If any, experimental support for these strategies is derived from studies with animal models of moderately severe focal ischemia instead of severe space-occupying infarction. None of the treatment options have improved outcome in randomized clinical trials. Two large nonrandomized studies of decompressive surgery yielded promising results in terms of reduction of mortality and improvement of functional outcome.
CONCLUSIONS: There is no treatment modality of proven efficacy for patients with space-occupying hemispheric infarction. Decompressive surgery might be the most promising therapeutic option. For decisive answers, randomized, controlled clinical trials are needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576974     DOI: 10.1097/01.CCM.0000050446.16158.80

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  25 in total

1.  Early decompressive hemicraniectomy following malignant ischemic stroke: the crucial role of timing.

Authors:  Matthew Vibbert; Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2010-01       Impact factor: 5.081

2.  Decompressive surgery in malignant infarction of the middle cerebral artery.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 3.  Hemicraniectomy for middle cerebral artery infarction.

Authors:  Hagen B Huttner; Eric Jüttler; Stefan Schwab
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

4.  In situ floating resin cranioplasty for cerebral decompression.

Authors:  Duck-Hyung Ahn; Dae-Won Kim; Sung-Don Kang
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

5.  Brain edema predicts outcome after nonlacunar ischemic stroke.

Authors:  Thomas W K Battey; Mahima Karki; Aneesh B Singhal; Ona Wu; Saloomeh Sadaghiani; Bruce C V Campbell; Stephen M Davis; Geoffrey A Donnan; Kevin N Sheth; W Taylor Kimberly
Journal:  Stroke       Date:  2014-10-21       Impact factor: 7.914

6.  High diastolic blood pressure is a risk factor for in-hospital mortality in complete MCA stroke patients.

Authors:  Valeria Caso; Giancarlo Agnelli; Andrea Alberti; Michele Venti; Monica Acciarresi; Francesco Palmerini; Maurizio Paciaroni
Journal:  Neurol Sci       Date:  2011-09-24       Impact factor: 3.307

Review 7.  Drug treatment of acute ischemic stroke.

Authors:  Sameer Bansal; Kiranpal S Sangha; Pooja Khatri
Journal:  Am J Cardiovasc Drugs       Date:  2013-02       Impact factor: 3.571

Review 8.  Treatment or prevention of complications of acute ischemic stroke.

Authors:  L J Kappelle; H B Van Der Worp
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

Review 9.  [Acute stroke therapy. Current developments].

Authors:  T Steiner; E Jüttler; P Ringleb
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

10.  Early complications of ischemic stroke.

Authors:  H Bart van der Worp; T W M Dianne Raaijmakers; L Jaap Kappelle
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.